Literature DB >> 5804950

L-cell virion ribonucleic acid.

A J Faras, R L Erikson.   

Abstract

"L-cell virion," obtained from chronically infected 929 L-cell lines, was purified on 70% sucrose pads and its ribonucleic acid (RNA) was extracted and analyzed on sucrose gradients. Two RNA components were isolated from the virion, a rapidly sedimenting species (82S) and a more slowly sedimenting species (6S). When the fast-moving component was heated to 45 C, it yielded a homogeneous peak which now sedimented at approximately 72S. Upon heating to 70 C, the peak dissociates into a smaller homogeneous RNA species with a sedimentation coefficient of approximately 33S. Ribonuclease treatment and base composition analysis revealed that the fast-moving species is a single-stranded molecule. Base ratio analysis also revealed that the small (6S) RNA component is similar in its base composition to L-cell ribosomal RNA and distinctly different from the base composition of the large (72S) RNA component. Actinomycin D inhibits production of the L-cell virion by the L-cell line.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5804950      PMCID: PMC375834     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Inhibition of protein synthesis by an RNA fraction from myeloblastosis virus.

Authors:  K C Olson; A O Denney; G S Breaudreau
Journal:  Biochim Biophys Acta       Date:  1968-07-23

2.  Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus.

Authors:  R A Bonar; L Sverak; D P Bolognesi; A J Langlois; D Beard; J W Beard
Journal:  Cancer Res       Date:  1967-06       Impact factor: 12.701

3.  The nucleic acid from avian myeloblastosis virus compared with the RNA from the Bryan strain of Rous sarcoma virus.

Authors:  W S Robinson; M A Baluda
Journal:  Proc Natl Acad Sci U S A       Date:  1965-12       Impact factor: 11.205

4.  Isolation of the nucleic acid of mouse mammary tumor virus (MTV).

Authors:  P H Duesberg; P B Blair
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

5.  An electron microscope study of virus-like particles in chick embryo and L cell cultures.

Authors:  A S Cromack
Journal:  J Gen Virol       Date:  1968-01       Impact factor: 3.891

6.  Further characterization of L-cell virions.

Authors:  D A Kindig; R Karp; W H Kirsten
Journal:  Proc Natl Acad Sci U S A       Date:  1968-04       Impact factor: 11.205

7.  Nucleic acid and proteins isolated from the Rauscher mouse leukemia virus (MLV).

Authors:  P H Duesberg; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

8.  Inhibition of Rauscher murine leukemia virus growth in vitro by actinomycin D.

Authors:  R E Bases; A S King
Journal:  Virology       Date:  1967-06       Impact factor: 3.616

9.  Virus-like particles in established murine cell lines: electron-microscopic observations.

Authors:  D A Kindig; W H Kirsten
Journal:  Science       Date:  1967-03-24       Impact factor: 47.728

10.  Virus particles and murine leukemia virus complement-fixing antigen in neoplastic and nonneoplastic cell lines.

Authors:  W T Hall; W F Andresen; K K Sanford; V J Evans; J W Hartley
Journal:  Science       Date:  1967-04-07       Impact factor: 47.728

View more
  3 in total

1.  RNA-dependent DNA polymerase activity in preparations of a mutant of Newcastle disease virus arising from persistently infected L cells.

Authors:  P A Furman; J V Hallum
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

2.  RNA-directed DNA synthesis by the DNA polymerase of Rous sarcoma virus: structural and functional identification of 4S primer RNA in uninfected cells.

Authors:  A J Faras; N A Dibble
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  Physiocochemical studies on L-cell virions.

Authors:  J L Nichols; K Quade; R B Luftig
Journal:  J Virol       Date:  1973-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.